Home » Topics » Regulatory » Patents

Patents
RSS

Mitsui Toatsu describes potent, long-acting and orally bioavailable antipsychotic agents

July 15, 1998

New semisynthetic macrolide antibiotics designed by Pliva

July 15, 1998

Centrally acting muscarinic agents discovered at American Home Products

July 15, 1998

Lilly describes serotonergic agents for treating obesity, CNS disorders

July 15, 1998

Potent, broad-spectrum cephalosporin antibiotics in the pipeline at Roche

July 15, 1998

SS Pharm. presents novel ACAT inhibitors for arteriosclerosis

July 14, 1998

Merck & Co.'s new tachykinin antagonists

July 14, 1998

Vertex describes new protease inhibitors as therapeutics for HCV

July 14, 1998

NPY Y1 receptor agonists from Ortho with anxiolytic activity

July 14, 1998

Hydroxamic acid-based MMP inhibitors described by P&U

July 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.